These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 7461509

  • 1. Biochemical study of adrenoleukodystrophy (ALD).
    Ogino T.
    Folia Psychiatr Neurol Jpn; 1980; 34(2):117-25. PubMed ID: 7461509
    [Abstract] [Full Text] [Related]

  • 2. An adult case of adrenoleukodystrophy with features of olivo-ponto-cerebellar atrophy: II. Lipid biochemical studies.
    Taketomi T, Hara A, Kitazawa N, Takada K, Nakamura H.
    Jpn J Exp Med; 1987 Feb; 57(1):59-70. PubMed ID: 3476777
    [Abstract] [Full Text] [Related]

  • 3. Adrenoleukodystrophy. Accumulation of cholesterol esters with very long chain fatty acids.
    Menkes JH, Corbo LM.
    Neurology; 1977 Oct; 27(10):928-32. PubMed ID: 561905
    [Abstract] [Full Text] [Related]

  • 4. Accumulation of hydrocarbon in a patient with adrenoleukodystrophy.
    Miki H, Matsuzawa Y, Ishibe T, Ishikawa K, Moriwaki K, Takahashi M, Tsumori T, Yamamoto A, Tarui S.
    J Neurol; 1983 Oct; 229(1):1-10. PubMed ID: 6189972
    [Abstract] [Full Text] [Related]

  • 5. Adrenoleukodystrophy brain cholesteryl esters and other neutral lipids.
    Ramsey RB, Banik NL, Davison AN.
    J Neurol Sci; 1979 Feb; 40(2-3):189-96. PubMed ID: 430102
    [Abstract] [Full Text] [Related]

  • 6. Very long-chain fatty acids in neutral lipids and glycerophospholipids of adrenoleukodystrophy-cultured skin fibroblasts.
    Sakai T, Antoku Y, Goto I, Ochiai J, Iwashita H, Kuroiwa Y, Katafuchi Y.
    J Neurol Sci; 1985 Dec; 71(2-3):301-6. PubMed ID: 4087027
    [Abstract] [Full Text] [Related]

  • 7. Myelin membrane from adrenoleukodystrophy brain white matter--biochemical properties.
    Brown FR, Chen WW, Kirschner DA, Frayer KL, Powers JM, Moser AB, Moser HW.
    J Neurochem; 1983 Aug; 41(2):341-8. PubMed ID: 6875541
    [Abstract] [Full Text] [Related]

  • 8. Cholesteryl esters and other neutral lipids in adrenoleukodystrophy brain.
    Ramsey RB, Banik NL, Davison AN.
    Biochem Soc Trans; 1978 Aug; 6(5):1027-9. PubMed ID: 744312
    [No Abstract] [Full Text] [Related]

  • 9. Adrenoleukodystrophy: abnormality of very long-chain fatty acids in erythrocyte membrane phospholipids.
    Antoku Y, Sakai T, Goto I, Iwashita H, Kuroiwa Y.
    Neurology; 1984 Nov; 34(11):1499-1501. PubMed ID: 6493501
    [Abstract] [Full Text] [Related]

  • 10. Adrenoleukodystrophy: evidence that abnormal very long chain fatty acids of brain cholesterol esters are of exogenous origin.
    Kishimoto Y, Moser HW, Kawamura N, Platt M, Pallante SL, Fenselau C.
    Biochem Biophys Res Commun; 1980 Sep 16; 96(1):69-76. PubMed ID: 7437052
    [No Abstract] [Full Text] [Related]

  • 11. A correlative study of the adrenal cortex in adreno-leukodystrophy--evidence for a fatal intoxication with very long chain saturated fatty acids.
    Powers JM, Schaumburg HH, Johnson AB, Raine CS.
    Invest Cell Pathol; 1980 Sep 16; 3(4):353-76. PubMed ID: 7462018
    [Abstract] [Full Text] [Related]

  • 12. Metabolism of [17,18-3H2]hexacosanoic acid and [15,16-3H2]lignoceric acid in cultured skin fibroblasts from patients with adrenoleukodystrophy (ALD) and adrenomyeloneuropathy (AMN).
    Tsuji S, Sano-Kawamura T, Ariga T, Miyatake T.
    J Neurol Sci; 1985 Dec 16; 71(2-3):359-67. PubMed ID: 4087029
    [Abstract] [Full Text] [Related]

  • 13. Adrenoleukodystrophy. The chain shortening of erucic acid (22:1(n-9)) and adrenic acid (22:4(n-6)) is deficient in neonatal adrenoleukodystrophy and normal in X-linked adrenoleukodistrophy skin fibroblasts.
    Christensen E, Grønn M, Hagve TA, Kase BF, Christophersen BO.
    Biochim Biophys Acta; 1989 Mar 14; 1002(1):79-83. PubMed ID: 2538146
    [Abstract] [Full Text] [Related]

  • 14. X-linked adrenoleukodystrophy: role of very long-chain acyl-CoA synthetases.
    Jia Z, Pei Z, Li Y, Wei L, Smith KD, Watkins PA.
    Mol Genet Metab; 2004 Mar 14; 83(1-2):117-27. PubMed ID: 15464426
    [Abstract] [Full Text] [Related]

  • 15. Cholesteryl lignocerate hydrolysis in adrenoleukodystrophy.
    Michels VV, Beaudet AL.
    Pediatr Res; 1980 Jan 14; 14(1):21-3. PubMed ID: 6767215
    [Abstract] [Full Text] [Related]

  • 16. Metabolism of saturated and polyunsaturated very-long-chain fatty acids in fibroblasts from patients with defects in peroxisomal beta-oxidation.
    Street JM, Singh H, Poulos A.
    Biochem J; 1990 Aug 01; 269(3):671-7. PubMed ID: 2117919
    [Abstract] [Full Text] [Related]

  • 17. Adrenoleukodystrophy: very long-chain fatty acid metabolism in fibroblasts.
    Rizzo WB, Avigan J, Chemke J, Schulman JD.
    Neurology; 1984 Feb 01; 34(2):163-9. PubMed ID: 6538003
    [Abstract] [Full Text] [Related]

  • 18. Lipid and fatty acid composition of brain tissue from adrenoleukodystrophy patients.
    Wilson R, Sargent JR.
    J Neurochem; 1993 Jul 01; 61(1):290-7. PubMed ID: 8515276
    [Abstract] [Full Text] [Related]

  • 19. Accumulation and defective beta-oxidation of very long chain fatty acids in Zellweger's syndrome, adrenoleukodystrophy and Refsum's disease variants.
    Poulos A, Singh H, Paton B, Sharp P, Derwas N.
    Clin Genet; 1986 May 01; 29(5):397-408. PubMed ID: 2427264
    [Abstract] [Full Text] [Related]

  • 20. Adrenoleukodystrophy: oleic acid lowers fibroblast saturated C22-26 fatty acids.
    Rizzo WB, Watkins PA, Phillips MW, Cranin D, Campbell B, Avigan J.
    Neurology; 1986 Mar 01; 36(3):357-61. PubMed ID: 3951702
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.